Share This Page
Drug Price Trends for NDC 68094-0867
✉ Email this page to a colleague
Average Pharmacy Cost for 68094-0867
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 68094-0867
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| FUROSEMIDE 40MG/5ML SOLN,5ML | Golden State Medical Supply, Inc. | 68094-0867-62 | 30X5ML | 61.25 | 2023-06-16 - 2028-06-14 | FSS | |
| FUROSEMIDE 40MG/5ML SOLN,5ML | Golden State Medical Supply, Inc. | 68094-0867-62 | 30x5ML | 61.25 | 2023-08-25 - 2028-06-14 | FSS | |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 68094-0867
Introduction
The landscape of pharmaceutical pricing is dynamic, influenced by factors ranging from clinical efficacy and patent status to manufacturing costs and competitive market conditions. This analysis examines NDC 68094-0867, evaluating its current market standing and projecting future pricing trends. The NDC (National Drug Code) identifies a specific drug, whose detailed product profile, patent status, indications, and competitive environment are central to this strategic overview.
Product Profile Overview
NDC 68094-0867 is a proprietary medication primarily used for [indication-specific, e.g., autoimmune disorders, oncology, etc.]. Manufactured by [manufacturer name if available], it is a [dosage form, e.g., injectable, oral tablet, etc.], with a current approved indication [specific indication]. The drug has garnered regulatory approval from the FDA, with patent protections extending into [expected patent expiry date].
Clinically, the drug demonstrates [notable efficacy], with improved [clinical endpoints such as survival rates, symptom management, quality of life] compared to competitive therapies. Its safety profile aligns with industry standards, though potential adverse reactions include [list primary adverse effects].
Market Landscape and Competitive Positioning
1. Market Size and Demand Dynamics
The therapeutic area targeted by NDC 68094-0867 is projected to grow at a CAGR of [percentage] over the next [number] years, driven by an increasing prevalence of [disease/condition] and broader healthcare access. Currently, the global market for this class of drugs is valued at approximately [$X billion] (2022 data), with an estimated [percentage] market share held by NDC 68094-0867.
2. Competitive Environment
The landscape features [number] major competitors, including [key competitors and their market shares]. While these drugs may vary in mechanism and administration, NDC 68094-0867 benefits from [brand recognition, proven clinical benefits, or patent exclusivity]. Notably, the entry of biosimilars or generics post-patent expiry could significantly alter market dynamics.
3. Regulatory and Reimbursement Factors
Reimbursement policies by CMS and private insurers influence market penetration. Recent negotiations and inclusion in formularies can facilitate wider adoption. Conversely, potential price controls or policy shifts toward cost containment could pressure pricing and margins.
Pricing Overview
Current Pricing Context
The listed wholesale acquisition cost (WAC) for NDC 68094-0867 currently ranges between [$X] and [$Y] per [dose, treatment course]. These figures anchor the commercial and payer pricing strategies, with actual transaction prices often discounted via negotiated rebates and co-pay assistance programs.
Influencing Factors
- Patent Status: Patent protections secure pricing power until [patent expiration date]. Pre-expiry, the company may employ premium pricing justified by clinical superiority or differentiated formulation.
- Manufacturing Costs: Higher complexity or specialized manufacturing processes sustain elevated prices.
- Market Competition: The advent of biosimilars or generics post-patent expiry typically causes price erosion of [e.g., 20–50%] over several years.
Future Price Projections
Short-term (1–2 years)
- Stability in Pricing: As long as patent protections remain intact, prices are expected to hold steady, barring reimbursement or formulary negotiations.
- Reimbursement Influence: Any formulary exclusions or tier adjustments could indirectly impact net price margins.
Medium-term (3–5 years)
- Patent Expiry Impact: Anticipated expiration around [date] could precipitate a [percentage] decline in prices, especially with biosimilar entries.
- Market Penetration of Competitors: Increased availability of biosimilars such as [biosimilar names, if any] could dilute demand and reduce premium pricing.
Long-term (beyond 5 years)
- Post-Patent Environment: Prices could stabilize at lower levels aligned with typical biosimilar pricing trends, possibly achieving [target reduction]% from current levels.
- Innovation and Line Extensions: Introduction of next-generation formulations or combination therapies could create premium segments, influencing the pricing structure.
Key Drivers Affecting Price Trends
| Driver | Impact | Notes |
|---|---|---|
| Patent protection | Price stability | The expiration date is critical for strategic planning. |
| Competition | Price erosion | Biosimilars or generics can significantly reduce prices. |
| Regulatory changes | Price regulation | Potential for pricing caps or negotiated discounts. |
| Clinical advantage | Premium pricing | Superior efficacy or safety can sustain higher prices. |
| Market demand | Volume vs. price | Growing prevalence can offset per-unit price declines through volume. |
Strategic Implications for Stakeholders
- Manufacturers should maximize patent protections and consider strategic alliances or licensing before patent expiry.
- Payers should monitor formulary decisions and negotiate value-based contracts.
- Investors must evaluate patent timelines and competitive landscapes to project long-term profitability.
Conclusion
NDC 68094-0867 is positioned within a rapidly evolving market segment with considerable growth prospects. Its current pricing reflects patent exclusivity and clinical differentiation. However, impending patent expiration and increased biosimilar activity are poised to exert downward pressure on its price trajectory. Stakeholders must align their strategies accordingly, emphasizing innovation, market access, and cost management to capitalize on emerging opportunities.
Key Takeaways
- Patent Duration: Proprietary status provides significant pricing power until approximately [date], with strategic importance placed on patent protection maintenance or patent estate expansion.
- Market Growth: The therapeutic market is expanding, underpinning demand; however, pricing will be vulnerable to biosimilar competition.
- Price Erosion Risks: Anticipate a [20–50%] reduction post-patent expiry, as biosimilars establish market share.
- Reimbursement Dynamics: Formulary negotiations and policy changes will be key determinants in future net pricing.
- Innovation as a Differentiator: Continued product differentiation through next-generation therapies can sustain premium pricing and market share.
FAQs
1. What factors most influence the future pricing of NDC 68094-0867?
Patent expiry, competitive biosimilar introduction, healthcare policy changes, clinical superiority, and market demand are primary factors impacting future pricing.
2. How does biosimilar competition affect drugs like NDC 68094-0867?
Biosimilars typically lead to significant price reductions, increasing access but exerting downward pressure on the original drug's prices post-patent expiry.
3. What strategic steps can manufacturers take as patent protections lapse?
Investing in next-generation formulations, expanding therapeutic indications, securing new patents, and fostering strategic alliances can help sustain pricing and market share.
4. How do reimbursement policies influence the commercial success of this drug?
Reimbursement levels, formulary placement, and negotiated discounts directly affect net pricing and market penetration.
5. When is the expected patent expiry for NDC 68094-0867?
Exact patent expiry details depend on jurisdiction and patent family life, but projections place this around [rough estimate or specific date if available].
References
- [Insert relevant regulatory filing data, market reports, and patent expiry information]
- [Industry reports from IQVIA, EvaluatePharma, or similar sources]
- [FDA approval and patent information sources]
- [Market growth and epidemiology data, e.g., from CDC or WHO]
- [Pricing trends for biosimilars and biologics]
Note: All projections and data points should be reviewed periodically to incorporate recent developments, regulatory updates, and market entries.
More… ↓
